Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Verizon announces expiration and final results of its tender offers for six series of debt securities
-
Iantrek Announces Peer-Reviewed Publication Highlighting 12-Month Safety and Effectiveness Results for its Bio-Interventional Uveoscleral Outflow Technology in Open-Angle Glaucoma Patients
-
CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors
-
Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy
-
TheRoyal.Land Integrates Cutting-Edge AI-Powered NPCs
-
RenovoRx CEO to Host Investor Fireside Chat on Tuesday, December 17th at 4:30 p.m. ET
-
Recent Bitcoin Gains and SEC Chairman Nominee Anticipated to Lay Strong Foundation for Rezolve Ai’s Vision to Make Crypto Mainstream
-
Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System
-
Filevine Proves Industry Leadership in Data Security with SOC 2 and SOC 3 Compliance
-
INmune Bio Inc. Completes Repayment of Silicon Valley Bank Debt
-
Acres Joins the REALTORS® Land Institute’s Member Advantage Program, Providing Advanced Land Intelligence to Members
-
AT&T Collaborates with Madison Energy Infrastructure to Deploy Community Solar in Maryland
-
authID Expands Workforce Verification Customer Base, Signs Agreement with TurboCheck to Combat Employment Identity Fraud
-
Immutep Announces Initiation of TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer
-
Standard Lithium Appoints Paul Collins to the Board of Directors
-
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter
-
aTyr Pharma Announces Third Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
-
Stingray and K2 Studios to Partner on EarthDay 365 FAST Channel and AVOD Offering
-
Nuvectis Pharma to Present at the 2024 Ladenburg Virtual Oncology Innovators & Investors Symposium
-
Oxford Lane Capital Corp. Provides November Net Asset Value Update
-
AmMax Bio and MD Anderson Announce Agreements to Advance Development of AMB-066 in Colorectal Cancer Patients with Minimal Residual Disease
-
Redwood Logistics Named in 2024 Gartner® Market Guide for Fourth-Party Logistics (4PL) for the Second Consecutive Year
-
SEALSQ Joins Forces with IC’ALPS To Accelerate Secure ASICs Development
-
NanoGraf Introduces Onyx™, High-Performance EV-Ready Silicon Anode
-
Stryker declares an $0.84 per share quarterly dividend
-
Medera’s Novoheart Releases Latest Cardiac Screening Innovation CTScreen v1.5 to Advance High-Throughput, Automated Human-Based Drug Testing
-
Duck Creek Technologies Strengthens Global Sales Leadership with Strategic Appointments in North America, EMEA, and APAC
-
Leapfrog Bio Presents Novel Genetic Sensitizing Mutation Linked to BET Inhibitors and Clinical Development Plans for Lead Product Candidate at the AACR Special Conference in Cancer Research
-
ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist
-
Man Group PLC : Form 8.3 - International Distribution Services plc
-
Man Group PLC : Form 8.3 - Spirent Communications plc
-
Man Group PLC : Form 8.3 - Britvic plc
-
Man Group PLC : Form 8.3 - Direct Line Insurance Group plc
-
Form 8.3 - Equipmake Holdings Plc
-
Man Group PLC : Form 8.3 - Aviva plc
-
S64 appointed to deliver cutting edge technology platform to enhance ODDO BHF’s private markets offering
-
Eneba Gets Ahead of Last-minute Holiday Rush with Instant-Delivery Digital Products
-
Vessels, undersea cables, and offshore oil installations increasingly becoming “gray zone” targets
-
Form 8.3 - Warpaint London Plc
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
Invesco Ltd: Form 8.3 - Aviva PLC; Public dealing disclosure
-
Alaska Energy Metals Extends Eureka Zone Mineralization 1.8 Kilometers to the Southeast, Nikolai Project, Alaska
-
Erdene Provides Corporate Finance Update
-
HPQ Silicon Signs Memorandum of Understanding (MOU) with Company in Northern Germany
-
LAVA Reports Third Quarter 2024 Financial Results and Announces Pipeline Reprioritization and Cash Runway Extension into 2027
-
VR Resources Confirms Mafic-Ultramafic Intrusion with Magmatic Sulfide in First Two Drillholes at Empire Project, Ontario
-
Ampligen Co-Inventor and Former CEO Agrees to Join AIM Scientific Advisory Board if Kellner Group Nominees Are Elected
-
Ocular Therapeutix™ to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Nayax Enables Discover® Global Network Cardholders to Use Their Preferred Payment Method Across EMEA
-
Psyence Biomed Executes Binding Agreements with Optimi Health Corp.

